Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2024 Annual Meeting | C191 - Essentials of Acute Treatment and Prevention of Ischemic Stroke

Thursday 04/18/24
07:00 AM - 09:00 AM MDT Add To Calendar
Colorado Convention Center | Mile High 1EF
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Joshua Z. Willey, MD
Cerebrovascular Disease and Interventional Neurology
Participants should become familiar with how to apply evidence-based medicine strategies to evaluate and treat a patient with thrombolysis, evaluate and refer patients for neuro-endovascular stroke treatment, and identify treatment options for patients with an acute ischemic stroke who are not eligibe for thrombolysis or endovascular stroke therapy.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge
Intermediate
Neurohospitalist
Fellow, Resident, General Neurologist, Advanced Practice Provider, Neurohospitalist
Case-based, Didactic

Program Materials Program Evaluations

Event Timeline
07:00 AM - 07:05 AM MDT Speaker Introduction
Joshua Z. Willey, MD
07:05 AM - 07:35 AM MDT Speaker Thrombolysis for Acute Ischemic Stroke, Approved and Expanded Indications
Sara Kate Rostanski, MD
07:35 AM - 07:45 AM MDT Speaker Questions & Answers
Sara Kate Rostanski, MD
07:45 AM - 08:15 AM MDT Speaker Endovascular Stroke Therapy for Acute Ischemic Stroke, Approved and Expanded Indications
Fawaz Al-Mufti, MD
08:15 AM - 08:25 AM MDT Speaker Questions & Answers
Fawaz Al-Mufti, MD
08:15 AM - 08:50 AM MDT Speaker Medical Management in Patients Ineligible for Thrombolysis or Endovascular Stroke Therapy
Joshua Z. Willey, MD
08:50 AM - 09:00 AM MDT Speaker Questions & Answers
Joshua Z. Willey, MD
Faculty Disclosures
Joshua Z. Willey, MD Dr. Willey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. Dr. Willey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Edwards Scientific. Dr. Willey has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for RECARDIO. Dr. Willey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbott. Dr. Willey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BrainQ. Dr. Willey has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of the American College of Cardiology. Dr. Willey has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Uptodate. The institution of Dr. Willey has received research support from NIH. Dr. Willey has received personal compensation in the range of $500-$4,999 for serving as a Review chapter author, MKSAP 16-20 with American College of Physicians.
Fawaz Al-Mufti, MD Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving as a Consultant for Stryker. Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving as a Consultant for Cerenovus. Dr. Al-Mufti has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Revalesio .
Sara Kate Rostanski, MD Dr. Rostanski has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for individual law firms.